News & research

News & Research

Find out what’s happening at MSWA, from our range of activities and programs to corporate news.

Also, read about the latest developments in neurological research, scientific discoveries, new medications and treatments in the areas of neurological conditions.

Check out our latest news

Thumbnail for 'An update about COVID-19'

An update about COVID-19

MSWA remains alert as we monitor the COVID-19 situation. This article provides a current updates and useful links for further information.

Read more
Thumbnail for 'Vumerity medication for relapsing-remitting MS, now approved under PBS'

Vumerity medication for relapsing-remitting MS, now approved under PBS

Vumerity® (diroximel fumarate) will be listed under the Pharmaceutical Benefit Scheme (PBS).

Read more
Thumbnail for 'We thank Ros Harman'

We thank Ros Harman

Ros Harman has announced her resignation from the MSWA Board after 18 years of service and valued contribution.

Read more
More news